Novel insights in classic versus relative glomerular hyperfiltration and implications on pharmacotherapy.
經典與相對性腎小球過濾增加的新見解及對藥物治療的影響。
Curr Opin Nephrol Hypertens 2023-02-22
Cardiovascular Risk Related to Glomerular Hyperfiltration in Nondiabetic Individuals: Increasing Visibility is Crucial.
非糖尿病個體腎小球過濾率增高相關的心血管風險:增加可見性至關重要。
Curr Hypertens Rev 2024-01-08
Advancements in diabetic kidney disease management: integrating innovative therapies and targeted drug development.
糖尿病腎病管理的進展:整合創新療法與針對性藥物開發。
Am J Physiol Endocrinol Metab 2024-05-20
Barriers to early diagnosis of chronic kidney disease and use of sodium-glucose cotransporter-2 inhibitors for renal protection: A comprehensive review and call to action.
慢性腎病早期診斷的障礙及鈉-葡萄糖共轉運蛋白-2抑制劑在腎臟保護中的應用:綜合評述與行動呼籲。
Diabetes Obes Metab 2024-08-14